Dyadic International Develops C1 Cell Lines And Manufactures Bundibugyo Ebolavirus Antigens Within 15 Days
DYAI•Dyadic develops and delivers Bundibugyo ebolavirus antigens
July 28 (Reuters) - Dyadic International Inc. DYAI.O:
- Dyadic International develops C1 cell lines and manufactures Bundibugyo ebolavirus antigens within 15 days.
- Dyadic International delivers C1-produced Bundibugyo ebolavirus antigens to FBS and Scripps for preclinical evaluation.
